New Delhi: With a variety of SARS-COV-2 mutations that appear in the near future, there may be a need for the country to adopt a dose of booster with the second generation Covid-19 vaccine, the word All India Institute of Medical Sciences (AIIMS) Head Dr.
Randeep Guleria.
“It seems that we might need a vaccine booster dose along with the passage of immunity time tends to fall.
There is immunity fading.
We want to have a booster dose that will cover various variants that appear,” Dr.
Guleria said in an interview with Ani.
He further stated that the booster dose would be the second generation vaccine.
“We will have a second generation vaccine that will be better in terms of the immunity they provide, covering a new variant and has a better overall efficacy.
The trace of the booster vaccine shooting has already taken place.
You might need a booster dose.
Until the end of this year.
But that Only after the population is vaccinated, the next step is to manage the booster dose, “Dr.
Guleria said.
Covaxin Bharat Biotech’s trials for children are currently underway and the results are expected to be released in September, Director of AIIMS told.
“Vaccines for children must come out now because trials in India already exist in vaccines available in India, Bharat Biotech trials are in the final phase in September we will have data,” he said.
The trial was carried out in three phases by separating children into the category according to their age.
The first trial began in the age group 12-18 years followed by a group of 6-12 years and 2-6 years which is currently undergoing a trial.
He further said that Zydus Cadila had entered data for children for their Covid-19 vaccine.
“The Zydus Cadila vaccine also includes children and the data already there.
They have applied for emergency use permits,” he said.
Zydus Cadila has concluded his trial for children between the age group 12 to 18 years.
AHMedabad-based pharmaceutical firm on July 1, requesting approval of emergency use for Zycov-D, the first three-dose shot – the first plasmid in the world, however, the DNA vaccine will, however, it becomes a few more days before the drug control drug controller General of India (DCGI) Give emergency use permission, according to the source.
Dr.
Guleria also said, “In the coming weeks or in September, vaccines must be available for children.
We must start school in a multilevel manner as we have done for 18-45 years and it will also provide protection to children And more confident to the public that children are safe.
“The Indian government has held discussions with moderna covid-19 vaccine manufacturers and Pfizer, to get their vaccines.
However, there is the same delay.
“There may be several reasons for delays.
I think two or three things to remember.
Someone is collaboration and understanding with the government at the dose.
But they also have to have a lot of doses to be given because we must understand it.
These companies have booked orders from many Country.
Thus, they have an obligation to provide vaccines to these countries.
Unless they fulfill the obligations, they cannot let go of doses for other countries such as India and other parts of the world.
They have pre-booked doses, “explained AIIMS head.
India has discussed with two companies on several problems including the neglect of compensation.
Previously, Dr.
V K Paul, Member (Health), Niti Aayog said, “We held a discussion.
This is the process of negotiation and dialogue.
We try to get a solution to contract problems and commitment.
This process is underway.”